Stay updated on HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial
Sign up to get notified when there's something new on the HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial page.

Latest updates to the HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial page
- Check6 days agoChange DetectedThe webpage has updated a date from December 24, 2024, to April 17, 2025.SummaryDifference1.0%
- Check13 days agoChange DetectedThe web page has been updated to version 2.15.0 from version 2.14.4, indicating a revision in the content. The phrase 'Here’s how you know' has been modified, suggesting a change in the way information is presented.SummaryDifference1.0%
- Check21 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4 and removed a date reference of 2025-03-25 while adding a new date of 2024-12-24.SummaryDifference1%
- Check28 days agoNo Change Detected
- Check64 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check78 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check85 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
Stay in the know with updates to HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HELIOS-A Study of Vutrisiran in hATTR Amyloidosis Clinical Trial page.